Valuation Trading Multiples & Precedent Transactions: Animal Health and Pet Care Manufacturers
Valuation benchmarks for Animal Health and Pet Care Manufacturers. Access public trading comps, EV/EBITDA acquisition multiples, and private market data for pitch books and valuation analysis.
1.1 - Animal Health and Pet Care Manufacturers Market Context & Valuation Drivers
Companies in this public trading comparables group develop and market animal health products spanning veterinary medicines, vaccines, diagnostics, supplements, and pet care consumables for companion animals and livestock. They monetize through branded product sales to veterinarians, distributors, retail and e-commerce channels. They are comparable for valuation benchmarks given similar regulatory profiles, R&D-driven pipelines, consumable mix, and exposure to the global animal health demand cycle.
Typical capabilities include discovery and manufacturing of prescription and OTC veterinary therapeutics, parasiticides and biologics; vaccine development and commercialization; diagnostic assays and genetic testing for disease detection and herd management; formulation of nutritional, joint, immune and gastrointestinal support products; GMP manufacturing and quality; regulatory affairs; multi-channel distribution through veterinary clinics, farm channels, retail and online; and brand management and category merchandising.
Primary customers include veterinary clinics and animal hospitals, livestock producers and agribusinesses, as well as retailers and pet owners via distributors and e-commerce. Key valuation metrics include organic revenue growth, gross and EBITDA margins, recurring consumables mix and customer retention, product approval cadence and pipeline productivity, and geographic channel penetration. These drivers support pricing power and cash flow visibility for comparable company analysis and valuation benchmarks.
2. Valuation Analysis: Public Trading Comps & Multiples for Animal Health and Pet Care Manufacturers companies
2.1 - Public Peer Groups & Median Valuation Multiples for Animal Health and Pet Care Manufacturers sector
Description: Companies in this public trading comparables group develop and market animal health products spanning veterinary medicines, vaccines, diagnostics, supplements, and pet care consumables for companion animals and livestock. They monetize through branded product sales to veterinarians, distributors, retail and e-commerce channels. They are comparable for valuation benchmarks given similar regulatory profiles, R&D-driven pipelines, consumable mix, and exposure to the global animal health demand cycle.
Description:
Provider of veterinary drugs and non-medicinal products dedicated to improving animal health and well-being, focusing on the development, production, and marketing of innovative solutions for pets and livestock.
Key Products:
Companion Animal Products: Comprehensive range of medical products for cats and dogs
Livestock Products: Medical products for cattle and pigs
Joint Support: Solutions for joint health and mobility
Immune Support: Products to boost the immune system of pets and livestock
Gastrointestinal Support: Treatments for digestive health.
Description:
Provider of animal health products, offering medicines, vaccines, diagnostic products, biodevices, and genetic tests to support the care and well-being of livestock and companion animals through innovative solutions and services globally.
Key Products:
Livestock medicines: Treatments for cattle, swine, poultry, fish, and sheep
Companion animal products: Healthcare solutions for dogs, cats, and horses
Vaccines: Protective immunization for various animal species
Diagnostic products: Tools for accurate disease detection and monitoring
Genetic testing: DNA-based diagnostic tests for animal breeding and health
Valuation FAQ: Animal Health and Pet Care Manufacturers
What is the current median EV/Revenue multiple for Animal Health and Pet Care Manufacturers?
Based on our index of public trading comparables, the median Enterprise Value to Revenue (EV/Rev) multiple for the Animal Health and Pet Care Manufacturers sector is currently
β.βx.
High-growth peers in the top quartile are trading at
ββ.βx.
View full data.
What is the average EV/EBITDA multiple for companies in this sector?
Profitable companies in the Animal Health and Pet Care Manufacturers sector trade at a median EV/EBITDA multiple of
ββ.βx.
This represents a change vs the 5-year historical average.
Our platform tracks EBITDA multiples for Animal Health and Pet Care Manufacturers and other key peer groups.
How have valuation multiples for Animal Health and Pet Care Manufacturers trended over the last 5 years?
Valuations have adjusted since 2021.
The sector saw peak multiples of ββ.βx EV/Revenue, settling to a 5-year average of β.βx today.
Access our Historical Trends chart for granular monthly data.
What are recent M&A transaction multiples in the Animal Health and Pet Care Manufacturers space?
Recent precedent transactions indicate implied enterprise values ranging from
β.βx to
ββ.βx Revenue.
Private market deals often trade at a liquidity discount compared to public peers.
Unlock the full list of precedent transactions.
Which public companies are used as trading comps for Animal Health and Pet Care Manufacturers?
The primary trading comparable group includes Animal Health and Pet Care Manufacturers.
Key constituents used for benchmarking include large-cap leaders and specialized mid-cap players.
See the full list of companies in the Public Trading Comps section.
How do I value a private company in the Animal Health and Pet Care Manufacturers sector?
Valuing a private Animal Health and Pet Care Manufacturers company typically involves applying current
EV/Revenue and EV/EBITDA multiples from public peers to the private company's financial metrics.
A discount for lack of marketability (DLOM) of 20-30% is often applied.
Our private company valuation database provides the exact multiples needed for this calculation.
What are the Animal Health and Pet Care Manufacturers industry valuation multiples for 2025?
For 2025, the Animal Health and Pet Care Manufacturers industry is trading at a median EV/Revenue multiple of
β.βx.
This reflects current market sentiment, interest rates, and growth expectations.
Access our platform to see how these multiples have changed from 2024 to 2025.
What is the difference between trading comps and transaction multiples for Animal Health and Pet Care Manufacturers?
Trading comps look at how public markets value similar companies today, while
transaction multiples (or precedent transactions) look at the price paid in past M&A deals.
Transaction multiples often include a "control premium," typically resulting in higher valuations than trading comps.
Our database tracks both trading multiples and M&A transaction multiples.
Ready to Find Valuation benchmarks?
Access complete buyer lists, valuation data, and M&A intelligence for Animal Health and Pet Care Manufacturers